• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    Ariad Pharmaceuticals Inc. (ARIA)

    -NasdaqGS
    7.91 Down 0.18(2.22%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:8.09
    Open:8.10
    Bid:7.89 x 800
    Ask:8.37 x 2200
    1y Target Est:9.15
    Beta:1.42
    Earnings Date:Aug 4 - Aug 10 (Est.)
    Day's Range:7.89 - 8.11
    52wk Range:4.90 - 9.89
    Volume:2,096,452
    Avg Vol (3m):3,992,340
    Market Cap:1.49B
    P/E (ttm):N/A
    EPS (ttm):-0.88
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARIA

    Comparison

    Symbol% ChgMkt Cap
    ARIADown 2.22%1.49B
    NVSUp 1.30%241.55B
    PFEDown 0.95%205.48B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):12.97
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.07
    Quarterly EPS Est (Jun-15) :-0.27
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):-0.20

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of medicines for cancer patients. The company offers Iclusig (ponatinib), a tyrosine kinase inhibitor (TKI) for the treatment of adult p... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback